Hematology-Oncology Therapy (2ND)

Hematology-Oncology Therapy (2ND)

  • ただいまウェブストアではご注文を受け付けておりません。 ⇒古書を探す
  • 製本 Hardcover:ハードカバー版/ページ数 1870 p.
  • 言語 ENG
  • 商品コード 9780071637893
  • DDC分類 616.99406

基本説明

A readily-accessible, up-to-date therapy guide for oncologic and non-neoplastic hematologic disorders, as well as supportive care.

Full Description


The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment RegimensA Doody's Core Title for 2021!More than 500 treatment regimensHematology-Oncology Therapy, Second Edition is an up-to-date, comprehensive therapy guide that delivers more than 500 treatment regimens in a succinct, uniform manner. The unique tabular design allows you to instantly locate and implement the proper treatment regimen. Supported by the latest practice guidelines, peer-reviewed literature, and the opinion of experts, Hematology-Oncology Therapy integrates extensive information that is critical to both office- and hospital-based practice of hematology and oncology.Hematology-Oncology Therapy is divided into three sections:Oncology:Provides detailed information about the administration, supportive care, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens, drugs, and biological agentsSupportive Care, Drug Preparation, Complications, and Screening:Consists of topics commonly encountered in clinical hematology-oncology practice, such as chemotherapy-induced nausea, oncologic emergencies, radiation complications, cancer pain management, cancer screening, and much moreSelected Hematologic Diseases:Delivers an authoritative guide to therapy for the principal diseases in consultative hematologyThis edition of Hematology-Oncology Therapy is enriched by the updating of all chapters as well as the addition of several new chapters; the new "Expert Opinion," which provides recommendations and guidance from experts on the use of treatment regimens; and inclusion of the latest regimens.

Contents

AuthorsPrefaceSECTION I: ONCOLOGY1. Adrenocortical Cancer, Peter F. Lebowitz and Tito Fojo2. Anal Cancer, David Ryan and Robert Mayer3. Biliary Tract Cancer: Gallbladder Cancer and Cholangiocarcinoma, Verena Sagaster and Werner Scheithauer4. Bladder Cancer, Edwin M. Posadas and William L. Dabut5. Brain Cancer, Lyndon Kim and Howard Fine6. Breast Cancer, Peter F. Lebowitz and Jo Anne Zujewski7. Carcinoid Tumors, Eva Tiensuu Janson and Kjell Oberg8. Carcinoma of Unknown Primary, David Spigel and F. Anthony Greco9. Cervical Cancer, Deirdre O'Mahony and Peter Rose10. Colorectal Cancer, Gregory Leonard and Jean Grem11. Endometrial Cancer, Deirdre O'Mahoney and Franco Muggia12. Esophageal Cancer, Gauri Varadhachary and Jaffer Ajani13. Gastric Cancer, Manish A. Shah, Dana Rathkopf, and Gary K. Schwartz14. Gestational Trophoblastic Neoplasia, Michael M. Boyiadzis and John Lurain15. Head and Neck Cancers, Erin Donovan and Barbara Conley16. Hepatocellular Carcinoma, Joan Maurel and Jordi Bruix17. HIV-Related Malignancies, Pallavi Kumar and Richard F. Little18. Leukemia, Acute Lymphoblastic (Adult), Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp19. Leukemia, Acute Myelogenous, Ivan Aksentijevich, Michael M. Boyiadzis, and Judith Karp20. Leukemia, Chronic Lymphocytic, Salah Abbasi and Bruce D. Cheson21. Leukemia, Chronic Myelogenous, Michael W.N. Deininger and Brian J. Druker22. Leukemia, Hairy Cell, Martin S. Tallman23. Lung Cancer, Enriqueta Felip and Rafael Rosell24. Lymphoma, Hodgkin, Christina M. Annunziata and Dan L. Longo25. Lymphoma, Non-Hodgkin, Kieron Dunleavy, David R. Kohler, and Wyndham H. Wilson26. Melanoma, Michael M. Boyiadzis and Barry Gause27. Mesothelioma, Verna Vanderpuye and Nicholas J. Vogelzang28. Multiple Myeloma, Robert Dean and Cynthia E. Dunbar29. Ovarian Cancer, Eddie Reed30. Pancreatic Cancer, Michael M. Boyiadzis and Daniel D. Von Hoff31. Pheochromocytoma, Michael M. Boyiadzis, Karel Pacak, and Tito Fojo32. Prostate Cancer, Peter F. Lebowitz and William L. Dabut33. Renal Cell Carcinoma, Michael M. Boyiadzis and Susan Bates34. Sarcomas, Janice Walshe, Tito Fojo, and Lee Helman35. Testicular Cancer, Michael M. Boyiadzis and Scott Saxman36. Thymic Carcinoma, Hanneke Wilmink and Guisseppe Giaconne37. Thyroid Cancer, Kenneth B. Ain38. Vaginal Cancer, Thomas Chen and Franco MuggiaSECTION II: SUPPORTIVE CARE, DRUG PREPARATION, COMPLICATIONS, AND SCREENING39. Chemotherapy-Induced Nausea and Vomiting: Prophylaxis and Treatment, Thomas E. Hughes40. Drug Preparation and Administration, David R. Kohler41. Chemotherapy Dose Modifications, Michael Menefee, Pamela W. McDevitt, and Tito Fojo42. Antineoplastic Drugs: Preventing and Managing Extravasation, David R. Kohler43. Indications for Growth Factors in the Hemotology-Oncology Setting, Pamela W. McDevitt and James N. Frame44. Indications for Bisphosphonates in the Hematology-Oncology Setting, Reem A. Shalabi, David R. Kohler, and James N. Frame45. Transfusion Therapy, Ashok Nambiar and Susan Leitman46. Oncologic Emergencies, Michael M. Boyiadzis and Tito Fojo47. Fever and Neutropenia, Juan Gea-Banacloche and Thomas J. Walsh48. Catheter-Related Bloodstream Infections: Managing and Prevention, Naomi P. O'Grady49. Venous Catheter-Related Thrombosis, McDonald Horne50. Complications and Follow-up After Hematopoietic Stem Cell Transplantation (HSCT), Michael M. Boyiadzis, Juan Gea-Banacloche, and Michael R. Bishop51. Radiation Complications, Diana Stripp and Eli Glatstein52. Cancer Pain: Assessment and Management, Ann Berger53. Hospice Care and End-of-Life Issues, Charles F. Von Gunten and David Weismann54. Cancer Screening, Jennifer Eng-Wong, Kathleen Calzone, and Sheila A. Prindiville55. Genetics of Common Inherited Cancer Syndromes, Kathleen Calzone, Jennifer Eng-Wong, and Sheila A. PrindivilleSECTION III: SELECTED HEMATOLOGIC DISEASES56. von Willebrand Disease, Michael M. Boyiadzis and Margaret E. Rick57. Hemophilia, Steven J. Jubelirer58. The Hypercoagulable State, Jeffrey I. Zwicker and Kenneth A. Bauer59. Heparin-Induced Thrombocytopenia (HIT) and HIT with Thromboembolic Syndrome (HITTS), McDonald K. Horne, III60. Autoimmune Hemolytic Anemia, James N. Frame61. Sickle Cell Disease: Acute Complications, James N. Frame, Steven J. Jubelirer, and Griffin P. Rodgers62. Aplastic Anemia, Michael M. Boyiadzis and Neal S. Young63. Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome (TTP/HUS), Kiarash Kojouri and James N. George64. Idiopathic Thrombocytopenic Purpura, Kiarash Kojouri and James N. George65. Polycythemia Vera, Celia L. Grosskreutz and Steven Fruchtman66. Essential Thrombocythemia, Celia L. Grosskreutz and Steven Fruchtman67. Myelodysplastic Syndromes, Michael M. Boyiadzis and Neal S. YoungNER(01): WOW